-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RXx6EYSxcGcuUq8ht5wG1fOBWhRlySmLNU5Zi8dTL1liNQsAGPAw3p7FFavvjZcj 0MtFm1+J1S3L7QKw2TLMyA== 0001193125-11-033794.txt : 20110214 0001193125-11-033794.hdr.sgml : 20110214 20110214062525 ACCESSION NUMBER: 0001193125-11-033794 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110214 DATE AS OF CHANGE: 20110214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Rosetta Genomics Ltd. CENTRAL INDEX KEY: 0001362959 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-82715 FILM NUMBER: 11602013 BUSINESS ADDRESS: STREET 1: 10 PLAUT STREET, SCIENCE PARK STREET 2: POB 4059 CITY: REHOVOT STATE: L3 ZIP: 76706 BUSINESS PHONE: 972-8-9484755 MAIL ADDRESS: STREET 1: 10 PLAUT STREET, SCIENCE PARK STREET 2: POB 4059 CITY: REHOVOT STATE: L3 ZIP: 76706 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PROMETHEUS LABORATORIES INC CENTRAL INDEX KEY: 0001141961 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330685754 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 9410 CARROLL PARK DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8588240895 MAIL ADDRESS: STREET 1: 9410 CARROLL PARK DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 SC 13G/A 1 dsc13ga.htm SCHEDULE 13G AMENDMENT NO. 1 Schedule 13G Amendment No. 1

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

 

Rosetta Genomics Ltd.

(Name of Issuer)

 

 

 

Ordinary Shares, par value NIS 0.01 per share

(Title of Class of Securities)

 

M82183 100

(CUSIP Number)

 

December 31, 2010

(Date of Event Which Requires Filing of This Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

  1   

NAME OF REPORTING PERSONS

 

Prometheus Laboratories Inc.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    California

NUMBER OF

SHARES

BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

    5    

SOLE VOTING POWER

 

    1,890,100 ordinary shares

   6   

SHARED VOTING POWER

 

    0 ordinary shares

   7   

SOLE DISPOSITIVE POWER

 

    1,890,100 ordinary shares

   8   

SHARED DISPOSITIVE POWER

 

    0 ordinary shares

  9

  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    1,890,100 ordinary shares

10

  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES    ¨

 

11

  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

    9.7%

12

  

TYPE OF REPORTING PERSON

 

    CO

 

Item 1(a). Name of Issuer:

Rosetta Genomics Ltd.

 

Item 1(b). Address of Issuer’s Principal Executive Offices:

10 Plaut Street, Science Park

Rehovot 76706 POB 4059, Israel

 

Item 2(a). Name of Person Filing:

Prometheus Laboratories Inc.

 

Item 2(b). Address of Principal Business Office or, if None, Residence:

9410 Carroll Park Drive

San Diego, CA 92121

 

Item 2(c). Citizenship:

California

 

Item 2(d). Title of Class of Securities:

Common stock, NIS 0.01 par value per ordinary share

 

Item 2(e). CUSIP Number:

M82183 100

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)    ¨    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)    ¨    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)    ¨    Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)    ¨   

Investment company registered under section 8 of the Investment Company Act of 1940

(15 U.S.C 80a-8);

(e)    ¨    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)    ¨    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)    ¨    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h)    ¨    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)    ¨    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)    ¨    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
(k)    ¨    Group, in accordance with §240.13d-1(b)(1)(ii)(K);

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:                                                                              

 

Item 4. Ownership

 

  (a) Amount beneficially owned:

 

     1,890,100 ordinary shares

 

  (b) Percent of class:

 

     9.7%

 

  (c) Number of shares as to which such person has:

 

  (i) Sole power to vote or to direct the vote:

1890,100 ordinary shares

 

  (ii) Shared power to vote or to direct the vote:

0 ordinary shares

 

  (iii) Sole power to dispose or to direct the disposition of:

1890,100 ordinary shares

 

  (iv) Shared power to dispose or to direct the disposition of:

0 ordinary shares

Item 5. Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ¨

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person:

Not applicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not applicable

 

Item 8. Identification and Classification of Members of the Group:

Not applicable

 

Item 9. Notice of Dissolution of Group:

Not applicable

 

Item 10. Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2011

 

/s/ William Franzblau

Name: William Franzblau
Title: Vice President, Legal Affairs and Secretary
Prometheus Laboratories Inc.
 -----END PRIVACY-ENHANCED MESSAGE-----